ICD-10-CM 2027 diagnosis code
Z94.81Bone marrow transplant status
Z94.81 is a valid, billable ICD-10-CM code for bone marrow transplant status. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.
Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About Z94.81
Z94.81 is the ICD-10-CM diagnosis code for bone marrow transplant status. It belongs to category Z94 (transplanted organ and tissue status), block Z77-Z99 (persons with potential health hazards related to family and personal history and certain conditions influencing health status) and chapter 21 (factors influencing health status and contact with health services). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.
Within Z94.8 (other transplanted organ and tissue status), Z94.81 is specifically for bone marrow transplant status. Related codes cover intestine transplant status (Z94.82), pancreas transplant status (Z94.83), stem cells transplant status (Z94.84) and other transplanted organ and tissue status (Z94.89).
As a secondary diagnosis it is a CC (complication or comorbidity), which can move an inpatient stay into the "with CC" MS-DRG of its family, unless the principal diagnosis excludes it.
In MS-DRG v44.0, it is part of the grouping logic for DRG 814 (Reticuloendothelial and Immunity Disorders with MCC, relative weight 2.0729), DRG 815 (Reticuloendothelial and Immunity Disorders with CC, relative weight 1.0444) and DRG 816 (Reticuloendothelial and Immunity Disorders without CC/MCC, relative weight 0.7381), in MDC 16 (Diseases and Disorders of the Blood and Blood Forming Organs and Immunological Disorders), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.
It is not acceptable as the principal diagnosis for an inpatient stay; it may be reported as a secondary diagnosis.
It is exempt from present-on-admission (POA) reporting, so no POA indicator is required.
It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.
Before ICD-10, this condition was coded in ICD-9-CM as V42.81 (bone marrow replaced by transplant).
Notes that apply from higher levels
Instructions written at a parent level also apply to Z94.81.
› From Z94 Transplanted organ and tissue status
- organ or tissue replaced by heterogenous or homogenous transplant
- complications of transplanted organ or tissue - see Alphabetical Index
- presence of vascular grafts (Z95.-)
Broader instructions also apply from Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status and Chapter 21: Factors influencing health status and contact with health services.
Alphabetic index entries
1 entriesTerms in the official ICD-10-CM index that lead to Z94.81.
MS-DRG v44.0 grouping
All DRGs →Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.
MDC 16 · Diseases and Disorders of the Blood and Blood Forming Organs and Immunological Disorders
ICD-9-CM equivalent
Converter →- V42.81Bone marrow replaced by transplantapproximate
From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about Z94.81
Is Z94.81 billable?
- Yes. Z94.81 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).
Can Z94.81 be used as a principal diagnosis?
- No. It is not acceptable as the principal diagnosis for an inpatient stay; it may be reported as a secondary diagnosis.
Is Z94.81 a CC or MCC?
- Z94.81 is a CC (complication or comorbidity) under MS-DRG v44.0, unless excluded by the principal diagnosis.
What DRG does Z94.81 group to?
- Z94.81 is used in the MS-DRG v44.0 logic for MS-DRG 814 (Reticuloendothelial and Immunity Disorders with MCC), MS-DRG 815 (Reticuloendothelial and Immunity Disorders with CC) and MS-DRG 816 (Reticuloendothelial and Immunity Disorders without CC/MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.